Literatur

9.9.9Selbsthilfegruppen und hilfreiche Websites

www.bsk-ev.org (Rehabilitationsaspekte), www.uveitisselbsthilfe.de, www.duag.org, uveitis.jimdo.com, www. orpha.net, www.uveitis-selbsthilfe.de, www.duag.org

Literatur

Literatur zu Abschn. 9.1

Baharivand N, Mahdavifard A, Fouladi RF (2013) Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial. Int Ophthalmol 33:39–46

Basu S, Biswas J, Pleyer U, Pathangay A, Manohar Babu B (2011) An ophthalmologist survey-based study of the atypical presentations and current treatment practices of ocular toxoplasmosis in India. J Parasit Dis 35:148–154

Boothroyd JC, Grigg ME (2002) Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Microbiol 5:438–442

Bosch-Driessen EH, Rothova A (1999) Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol 128:421–425 Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A (2002a)

Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109:869–878

Butler NJ, Furtado JM, Winthrop KL, Smith JR (2013) Ocular toxoplasmosis II: clinical features, pathology and management. Clin Experiment Ophthalmol 41:95–108

de-la-Torre A, Rios-Cadavid AC, Cardozo-Garcia CM, Gomez-Marin JE (2009) Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral centre in Colombia. Br J Ophthalmol 93:1001–1004

de Souza EC, Casella AM (2009) Clinical and tomographic features of macular punctate outer retinal toxoplasmosis. Arch Ophthalmol 127:1390–1394

Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, Ten Dam-van Loon N, Muccioli C, Hovakimyan A, Barisani-Asenbauer T (2008) Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol 146(e852):856–865 Doft BH, Gass DM (1985) Punctate outer retinal toxoplasmosis. Arch

Ophthalmol 103:1332–1336

Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP (2010) Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends in parasitology 26:190

Fardeau C, Romand S, Rao NA, Cassoux N, Bettembourg O, Thulliez P, Lehoang P (2002) Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol 134:196–203

Garweg JG, Scherrer JN, Halberstadt M (2008) Recurrence characteristics in European patients with ocular toxoplasmosis. Br J Ophthalmol 92:1253–1256

Gilbert RE, See SE, Jones LV, Stanford MS (2002) Antibiotics versus control for toxoplasma retinochoroiditis. Ophthalmol 114:136–144 (Cochrane Database Syst Rev, CD002218)

Goldenberg D, Goldstein M, Loewenstein A, and Habot-Wilner Z. (2013) Vitreal, retinal, and choroidal findings in active and scarred toxoplasmosis lesions: a prospective study by spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 251(8):2037–2045

Goldmann H, Witmer R (1954) Antibodies in the aqueous humor. Ophthalmologica 127:323–330

Grigg ME, Ganatra J, Boothroyd JC, Margolis TP (2001) Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 184:633–639

Janku J (1923) Pathogenesa a pathologická anatomie tak nazvaneho vrozeného kolombu žluté skvrany voku normálné velikem a microphthalmickém s nalezem parasitu v sítnici. Casopis Lekareu Ceskyck 62:1021–1027 (1054–1059, 1081–1085, 1111–1115, 1138–1143)

Jasper S, Vedula SS, John SS, Horo S, Sepah YJ, Nguyen QD (2013) Corticosteroids for ocular toxoplasmosis. Cochrane Database Syst Rev Apr 30; 4:CD007417

Jones JL, Dubey JP (2010) Waterborne toxoplasmosis-Recent developments. Experimental Parasitology 124:10

Kim SJ, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS, Recchia FM (2013) Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology 120:371–8 Labalette P, Delhaes L, Margaron F, Fortier B, Rouland JF (2002) Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol 133:506–515 Meenken C, Rothova A, de Waal LP, van der Horst AR, Mesman BJ, Kijlstra A (1995) HLA typing in congenital toxoplasmosis. Br J Ophthalmol

79:494–497

Nicolle C, Manceaux L (1908) Sur une infection a corps de leishman (ou organisms voisins) du gondii. C R AcadSci (Paris) 147:763–766

Pleyer U, Torun N, Liesenfeld O (2007) Okuläre Toxoplasmose. Ophthalmologe 104:603–15

Shobab L, Pleyer U, Johnsen J, Metzner S, James ER, Torun N, Fay MP, Liesenfeld O, Grigg ME (2013) Toxoplasma serotype predicts development of ocular toxoplasmosis. J Infect Dis 208(9):1520–8

Silveira C, Belfort R Jr., Muccioli C, Holland GN, Victora CG, Horta BL, Yu F, Nussenblatt RB (2002) The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 134:41–46

Soheilian M, Ramezani A, Azimzadeh A, Sadoughi MM, Dehghan MH, Shahghadami R, Yaseri M, Peyman GA (2011) Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology 118:134–141

Torun N, Sherif Z, Garweg J, Pleyer U (2008) Diagnosis and treatment of ocular toxoplasmosis: a survey of German-speaking ophthalmologists. Ophthalmologe 105:1023–1028

Vasconcelos-Santos DV et al (2009) Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 116:2199–205

Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, Peyron F (2004) Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113:1567–1572

Wendte JM, Gibson AK, Grigg ME (2011) Population genetics of Toxoplasma gondii: new perspectives from parasite genotypes in wildlife. Vet Parasitol 182:96–111

Literatur zu Abschn. 9.2

Ahn SJ, Woo SJ, Hyon JY, Park KH (2013) Cataract formation associated with ocular toxocariasis. J Cataract Refract Surg 39:830–835

Amin HI, McDonald R, Han DP (2000) Vitrectomy update for macular traction in ocular toxocariasis. Retina 20:80–85

Barisani-Asenbauer T, Maca SM, Hauff W (2001) Treatment of ocular toxocariasis with albendazole. J Ocul Pharmacol Ther 17:287–294 Bertelmann E, Velhagen KH, Pleyer U (2003) Okuläre Toxokariasis: Diagnostische und therapeutische Optionen. Ophthalmologe

100:1912–1015

10

11

12

13

14

15

16

17

18

19

20

21

22

388 Kapitel 9  •  Infektiös

Bertelmann E, Velhagen KH, Pleyer U (2007) Okuläre Toxokariasis: Von der Biologie zur Therapie. Ophthalmologe 104:35–39

Davidson R, Mermer A, Oeinis O (2012) Toxocara cati larva migrans in domestic pigs – detected at slaughterhouse control in Norway. Acta Vet Scand 54:66

Fillaux J, Magnaval JF (2013) Laboratory diagnosis of human toxocariasis. Vet Parasitol 193:327–336

Kayser FH, Bienz KA, Eckert J (1989) Medizinische Mikrobiologie, 7. Aufl. Thieme, Suttgart, New York, S 450–451

Kim YJ, Moon CH, Chang JH (2013) Toxocariasis of the optic disc. J Neuroophthalmol 33:151–152

Negri EC, Santarem VA, Rubinsky-Elefant G, Giuffrida R, da Vieira Silva A (2013) Anti-toxocara spp. antibodies in an adult healthy population: serosurvey and risk factors in southeast Brazil. Asian Pac J Trop Biomed 3:211–216

Pollard ZF, Jarrett WH, Hagler WS, Allain DS, Schantz PM (1979) ELISA for diagnosis of ocular toxocariasis. Ophthalmology 86:743–749 Raistrick ER, Hart JCD (1976) Ocular toxocariasis in adults. Br J Ophthal-

mol 60:365–370

Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU (2010) Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol 104:3–23

Smith H, Holland C, Taylor M, Magnaval JF, Schantz P, Maizels R (2009) How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol 25:182–188

Stewart JM, Cubillan LD, Cunningham ET Jr (2005) Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina 25:1005–1013

Tost F, Hellmann A, Ockert G (1998) Toxocara canis Infektion: Umweltparasitologische und epidemiologische Untersuchung. Ophthalmologe 95:486–489

Werner JC, Ross RD, Green R, Watts JC (1999) Pars plana vitrectomy and subretinal surgery for ocular toxocariasis. Arch Ophthalmol 117:532–534

Wilder HC (1950) Nematode endophthalmitis. Trans Am Acad Ophthalmol Otolaryngol 50:99–109

Woodhall D, Starr MC, Montgomery SP, Jones JL, Lum F, Read RW, Moorthy RS (2012) Ocular toxocariasis: epidemiologic, anatomic and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology 119:1211–1217

Literatur zu Abschn. 9.3

Boniuk I (1972) The cytomegalovirus and the eye. Int Ophthalmol Clin 12(2):169–190

Carson S, Chatterjee SN (1978) Cytomegalovirus retinitis: Two cases occurring after renal transplantation. Ann Ophthalmol 10:275–279

Cinatl J Jr., Kotchetkov R, Weimer E et al (2000) The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus induced upregulationf IL-8 and ICAM-1 in cultured human fibroblasts. J Med Virol 60(3):313–323

Culbertson WW (1989) Infections of the retina in AIDS. Int Ophthalmol Clin 29:108–118

Cunningham ET, Belfort R (2002) HIV/AIDS and the Eye: A Global Perspective Ophthalmology Monograph Bd. 15. American Academy of Ophthalmology, Oxford University Press, New York, S 4–5

Guembel HO, Hofmann F, van Even G et al (1996) Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cmv retinitis and patients with AIDS. Ger J Ophthalmol 5:490–491

Gümbel HO, Koch FH (1998) Drug targeting in cytomegalovirus retinitisintravitreal implantation of ganciclovir drug carriers. Ophthalmologe 95:58–63

Gümbel HO, Ohrloff C (1997) Opportunistic infections of the eye in immunocompromised patients. Ophthalmologica 211:53–61

Heinemann M (1989) Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch OPhthalmol 96:367–374

Holbrook JT, Colvin R, Van Natta ML et al (2011) Evaluation of the United States Health Service guidelines for discontinuation of anti-CMV therapy after immune recovery in patients with CMV retinitis. Am J OPhthalmol 152(4):628–637

Jabs DA (1988) AIDS retinopathy: Findings and significance. Ophthalmol Clin North Am 1:101–105

Jabs DA, Enger C, Haller J et al (1991) Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol 109:794–799

Jabs DA, Ahuja A, Van Natta M et al (2010) Course of Cytomegalovirus Retinitis in the era of HAART: Five-year outcome. Ophthalmology 117(11):2152–2161

Liebermann RM, Orellana J, Melton RC (1994) Efficiacy of intravitreal foscarnet in a patient with AIDS. New Engl J Med 330:868–869 Pomerantz RJ, Kuritzkes DR, de la Monte SM et al (1987) Infection of

the retina by human immunodeficiency virus type. N Engl J Med 1(317):1643–1647

RKI, Epidemiologisches Bulletin, 26. November 2012/Nr. 47, S. 470 Smith TJ, Pearson A, Blandford DI et al (1992) Intravitreal sustained-

release ganciclovir. Arch Ophtalmol 110:255–258

Stenson SM, Friedberg DN (1995) AIDS and the Eye Contact Lens Association of Ophthalmologists 14–15

Thome JE, Van Natta ML, Jabs DA et al (2011) Visual field loss in patients with cytomegalovirus retinitis. Ophthalmology 118(5):895–901

Literatur zu Abschn. 9.4

Abe T, Tsuchida K, Tamai M (1996) A comparative study of the polymerase chain reaction and local antibody production in acute retinal necrosis syndrome and cytomegalovirus retinitis. Graefe’s Arch Clin Exp Ophthalmol 234:419–24

Ando F, Kato M, Goto S (1983) Platelet function in bilateral acute retinal necrosis. Am J Ophthalmol 96:27–32

Balansard B, Bodaghi B, Cassoux N et al (2005) Necrotising retinopathies simulating acute retinal necrosis syndrome. B J Ophthalmology 89:96–101

Blumenkranz MS, Culbertson WW, Clarkson JG (1986) Treatment of the acute retinal Necrosis syndrome with intravenous acyclovir. Ophthalmology 93(3):1317–25

Bodaghi B, LeHoang P et al (2009) Herpetic Viral Retinopathies (ARN, PORN and Non-necrotizing Herpetic Retinopathies). In: Gupta A, Gupta V, Herbort CP (Hrsg) UveitisText and Imaging. Jaypee Brothers, New Dehli, S 623–633

Boer JH, Verhagen C, Bruinenberg M (1996) Serologic and Polymerase Chain Reaction Analysis of Intraocular Fluids in the Diagnosis of Infectious Uveitis. Am J Ophthalmol 121:650–8

Chong DY, Johnson MW, Huynh TH et al (2009) Vitreous Penetration of Orally Administered Famciclovir. AmJOphthalmology 148(1):38–42 Culbertson WW, Blumenkranz MS, Haines H (1982) The acute retinal necrosis syndrome part 2. Histopathology and etiology. Ophthal-

mology 89:1317

Elion GB, Furman PA, Fyfe JA et al (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA 74:5716–20

Field HF (2001) Herpes simplex virus antiviral drug resistance-current trends and future prospects. JclinVirol 21:261–9

Forster DJ, Dugel PU, Frangieh GT et al (1990) Rapidley progressive outer retinal necrosis in the acquired immunodeficiency syndrome. AmJOphthalmol 110:341–48

Ganatra JB, Chandler D, Santos BS et al (2000) Viral Causes of the Acute Retinal Necrosis Syndrome. AmJOphthalmol 129:166–72

Literatur

Hillenkamp J, Nölle B, Bruns C et al (2009) Acute Retinal Necrosis: Clinical Features, Early Vitrectomy and Outcomes. Ophthalmolgy 116(10):1971–5

Holland GN, Cornell PJ, Park MS et al (1989) An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4. AmJOphthalmol 108(4):370–74

Holland GN, Executive Committee of the American Uveitis Society (1994) Standard Diagnostic Criteria for the Acute Retinal Necrosis Syndrome. AmJOphthalmol 117(5):663–67

Jeon S, Kakizaki H, Lee WK et al (2012) Effect of Prolonged Oral Acyclovir Treatment in Acute Retinal Necrosis. Ocular Immunology and Inflammation 20(4):288–92

Palay D, Sternberg P, Davis J (1991) Decrease in the Risk of Bilateral Acute Retinal Necrosis by Acyclovir Therapy. Ophthalmology 112:250–5 Park JJ, Pavesio C (2008) Prophylactic laser photocoagulation for acute retinal necrosis: Does it raise more questions than answers? Br-

JOphthalmol: 92:9: 1161–2

Pleyer U, Winterhalter S (2010) Diagnostik und Therapie der Herpesvirusassoziierten Uveitis. Klin Monatsbl Augenheilkd 227:1–6

Rothova A, de Boer JH, Ten Dam-van Loon NH et al (2008) Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Ophthalmology 115:306–11

Scott IU, Luu KM, Davis JL (2000) Intravitreal Antivirals in the Management of Immunocompetent Patients With Necrotizing Herpetic Retinopathy. AmJOphthalmol 129(6):811–13

Silva RA, Berrocal AM, Moshfeghi DM et al (2012) Herpes simplex virus type 2 mediated acute retinal necrosis in a pediatric population: case series and review. GraefesArchClinExpOphthalmol

Tam PMK, Hooper CY, Lightman S (2010) Antiviral selection in the management of acute retinal necrosis. ClinOphthalmol 4:11–20

Taylor SRJ, Hamilton R, Hooper CY et al (2012) Valacyclovir in the treatment of acute retinal necrosis. Ophthalmology 12:48

Tran TH, Bodaghi B, Rozenberg F (2004) Prise en charge diagnostique et therapeutique des rétinites nécrosantes herpétiques. JFrOphtalmol 27(3):223–36

Urayama A, Yamada N, Sasaki T (1971) Unilateral acute uveitis with periarteritis and detachment. JpJClinOphthalmol 25:607–19

Winterhalter S, Adams Althaus OC et al (2007) Akute Retinanekrose. Klin Monatsbl Augenheilkd 24:567–74

Wong R, Pavesio CE, Laidlaw DAH et al (2010) The Effects of Intravitreal Foscarnet and Virus Type on Outcome. Ophthalmology 117(3):556– 60

Wong RW, Jumper JM, McDonald HR et al (2012) Emerging concepts in the management of acute retinal necrosis. BJOphthalmology online First, published on December 21, 2012 as 10.1136/bjoph- thalmol-2012-301983

Young NFA, Bird AC (1978) Bilateral acute retinal necrosis: 62: 581–90

Literatur zu Abschn. 9.5

Boulouis HJ et al (2005) Factors associated with the rapid emergence of zoonotic Bartonella infections. Vet Res 36(3):383–410

Chomel BB, Kasten RW (2010) Bartonellosis, an increasingly recognized zoonosis. J Appl Microbiol 109(3):743–50

Cunningham ET, Koehler JE (2000) Ocular bartonellosis. Am J Ophthalmol 130(3):340–9

Drancourt M et al (2008) High prevalence of fastidious bacteria in 1520 cases of uveitis of unknown etiology. Medicine (Baltimore) 87(3):167–76

Kalogeropoulos C et al (2011) Bartonella and intraocular inflammation: a series of cases and review of literature. Clin Ophthalmol 5:817–29 Kamoi K et al (2009) Seroprevalence of Bartonella henselae in patients with uveitis and healthy individuals in Tokyo. Jpn J Ophthalmol

53(5):490–3

Kerkhoff FT, Rothova A (2000) Bartonella henselae associated uveitis and HLA-B27. Br J Ophthalmol 84(10):1125–9

Mietze A (2010) Bartonella henselae in Katzen, Hunden und Zecken in Deutschland. Tierärztliche Hochschule Hannover, Hannover

Ormerod LD, Dailey JP (1999) Ocular manifestations of cat-scratch disease. Curr Opin Ophthalmol 10(3):209–16

Rothova A et al (1998) Bartonella serology for patients with intraocular inflammatory disease. Retina 18(4):348–55

Literatur Abschn. 9.6

Cortez R, Denny JP, Muci-Mendoza R, Ramirez G, Fuenmayor D, Jaffe GJ (2005) Diffuse unilateral subacute neuroretinitis in Venezuela. Ophthalmology 112(12):2110–2114

De Souza EC, Abujamra S, Nakashima Y, Gass JD (1999) Diffuse bilateral subacute neuoretinitis: first patient with documented nematodes in both eyes. Arch Ophthalmol 117(10):1349–1351

De Souza EC, Nakashima Y (1995) Diffuse unilateral subacute neuroretinitis. Report of transvitreal surgical removal of a subretinal nematode. Ophthalmology 102:1183–1186

Garcia CA, Gomes AH, Garcia Filho CA, Vianna RN (2004) Early-stage diffuse unilateral subacute neuroretinitis: improvement of vision after photocoagulation of the worm. Eye 18(6):624–627

Garcia CA, Gomes AH, Vianna RN, Souza Filho JP, Garcia Filho CA, Oréfice F (2005) Late-stage diffuse unilateral subacute neuroretinitis: Latestage diffuse unilateral subacute neuroretinitis: photocoagulation of the worm does not improve the visual acuity of affected patients. Int Ophthalmol 26(1–2):39–42

Garcia CA, Sabrosa NA, Gomes AB, Segundo Pde S, Garcia Filho CA, Sabrosa AS (2008) Diffuse Unilateral Subacute Neuroretinitis-DUSN. Int Ophthalmol Clin 48(3):119–29

Gass JD, Braunstein RA (1983) Further observations concerning the diffuse unilateral subacute neuroretinitis syndrome. Arch Ophthalmol 101(11):1689–1697

Gass JD, Gilbert WR Jr, Guerry RK, Scelfo R (1978) Diffuse unilateral subacute neuroretinitis. Ophthalmology 85(5):521–545

Gass JD, Scelfo R (1978) Diffuse unilateral subacute neuroretinitis. J R Soc Med 71(2):95–111

Goldberg MA, Kazacos KR, Boyce WM, Ai E, Katz B (1993) Diffuse unilateral subacute neuroretinitis. Morphometric, serologic, and epidemiologic support for Baylisascaris as a causative agent. Ophthalmology 100:1695–1701

Matsumoto BT, Adelberg DA, DelPriore LV (1995) Transretinal membrane formation in diffuse unilateral subacute neuroretinitis. Retina 15(2):146–149

McDonald HR (2003) Diagnostic and therapeutic Challenges. Diffuse unilateral subacute neuroretinitis. Retina 23(1):92–96

Meyer-Riemann W, Petersen J, Vogel M (1999) An attempt to extract an intraretinal nematode located in the papillomacular bundle. Klin Monatsbl Augenheilkd 214(2):116–119

Moraes LR, Cialdini AP, Avila MP, Elsner AE (2002) Identifying live nematodes in diffuse unilateral subacute neuroretinitis by using the scanning laser ophthalmoscope. Arch Ophthalmol 120(2):135–138 Myint K, Sahay R, Mon S, Saravanan VR, Narendran V, Dhillon B (2006) „Worm in the eye“: the rationale for treatment of DUSN in south

India. Br J Ophthalmol 90(9):1125–1127

Oueghlani E, O’Sullivan E, Pavesio CE (2010) Diffuse unilateral subacute Neuroretinitis in the United Kingdom. Int Ophthalmol 30(5):615– 619

Parsons HE (1952) Nematode chorioretinitis; report of a case, with photographs of a viable worm. AMA Arch Ophthalmol 47(6):799–800 Sabrosa NA, de Souza EC (2001) Nematode infections of the eye: toxocariasis and diffuse unilateral subacute neuroretinitis. Curr Opin

Ophthalmol 12(6):450–454

10

11

12

13

14

15

16

17

18

19

20

21

22

390 Kapitel 9  •  Infektiös

Schatz H, McDonald HR, Johnson RN (1997) Diagnostic and therapeutic challenges. Retina 17:440–443

Vedantham V, Vats MM, Kakade SJ, Ramasamy K (2006) Diffuse unilateral subacute neuroretinitis with unusual findings. Am J Ophthalmol 142(5):880–883

Venkatesan P (1998) Albendazole. J Antimicrob Chemother 41(2):145– 147

Vianna RN, Onofre G, Ecard V, Muralha L, Muralha A, de Garcia ACA (2006) Indocyanine green angiography in diffuse unilateral subacute neuroretinitis. Eye 20(9):1113–1116

Literatur zu Abschn. 9.7

Adelman RA, Membreno JH, Afshari NA, Stoessel KM (2003) West Nile virus chorioretinitis. Retina 23:100–1

Agahan AL, Torres J, Fuentes-Páez G, Martínez-Osorio H, Orduña A, Calonge M (2011) Intraocular inflammation as the main manifestation of Rickettsia conorii infection. Clin Ophthalmol 5:1401–7

Afshar AR, Hariprasad SM, Jampol LM, Sheth VS (2012) Use of intravitreous bevacizumab to treat macular edema in West Nile virus chorioretinitis. Arch Ophthalmol 130:396–8

Al-Hazmi A, Al-Rajhi AA, Abboud EB et al (2005) Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology 112:313–8

Alpert SG, Fergerson J, Noel LP (2003) Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 136:733–5

Anninger WV, Lomeo MD, Dingle J, Epstein AD, Lubow M (2003) West Nile virus associated optic neuritis and chorioretinitis. Am J Ophthalmol 136:1183–5

Anninger W, Lubow M (2004) Visual loss with West Nile virus infection: a wider spectrum of a„new“ disease. Clin Infect Dis 38:55–6

Bacsal K, Chee SP, Cheng CL, Flores JV (2007) Arch Ophthalmol 125:501– 10

Balkhy HH, Memish ZA (2003) Rift Valley fever: an uninvited zoonosis in the Arabian peninsula. Int J Antimicrob Agents 21(2):153–7

Bains HS, Jampol LM, Caughron MC, Parnell JR (2003) Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol 121:205–7

Bird BH, Maartens LH, Campbell S et al (2011) Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep. J Virol 85(24):12901–9

Blacksell SD, Newton PN, Bell D et al (2006) The comparative accuracy of 8 commercial rapid immunochromatographic assays for the diagnosis of acute dengue virus infection. Clin Infect Dis 42:1127–34 Brighton SW, Prozesky OW, de la Harpe AL (1983) Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J 1983; 63:313–Brighton SW (1984) Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study. S Afr Med

J 66:217–8

Briolant S, Garin D, Scaramizzino N, Jouan A, Crance JM (2004) In vitro inhibition of Chikungunya and Semliki Forest viruses replicationby antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res 61:111–7

Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT (2012) Chikungunya: a re-emerging virus. Lancet 379(9816):662–71

Chan CK, Limstrom SA, Tarasewicz DG, Lin SG (2006) Ocular features of west nile virus infection in North America: a study of 14 eyes. Ophthalmology 113:1539–46

Chan DP, Teoh SC, Tan CS et al (2006) Ophthalmic complications of Dengue. Emerg Infect Dis 12:285–9

Cruz-Villegas V, Berrocal AM, Davis JL (2003) Bilateral choroidal effusions associated with dengue fever. Retina 23:576–8

Chhabra M, Mittal V, Bhattacharya D, Rana U, Lal S (2008) Chikungunya fever: a re-emerging viral infection. Indian J Med Microbiol 26:5–12 Chia A, Luu CD, Mathur R, Cheng B, Chee SP (2006) Electrophysiological findings in patients with dengue-related maculopathy. Arch Oph-

thalmol 124(10):1421–6

Chlebicki MP, Ang B, Barkham T, Lande A (2005) Retinal hemorrhages in 4 patients with dengue fever. Emerg Infect Dis 11:770–1

De Amorim Garcia CA, Gomes AH, De Oliveira AG (2006) Bilateral stellar neuroretinitis in a patient with dengue fever. Eye 20(12):1382–3

de Groot-Mijnes JD, de Visser L, Zuurveen S, Martinus RA, Völker R, ten Dam-van Loon NH, de Boer JH, Postma G, de Groot RJ, van Loon AM, Rothova A (2010) Identification of new pathogens in the intraocular fluid of patients with uveitis. Am J Ophthalmol 150(5):628–36

De Lamballerie X, Boisson V, Reynier JC et al (2008) On chikungunya acute infection and chloroquine treatment. Vector Borne Zoonotic Dis 8:837–9

Eidsness RB, Stockl F, Colleaux KM (2005) West Nile chorioretinitis. Can J Ophthalmol 40:721–4

Faridi OS, Ranchod TM, Ho LY, Ruby AJ (2010) Pandemic 2009 influenza A H1N1 retinopathy. Can J Ophthalmol 45:286–287

Fukushi S, Nakauchi M, Mizutani T, Saijo M, Kurane I, Morikawa S (2012) Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein using new monoclonal antibodies. J Virol Methods 180(1–2):68–74

Garg S, Jampol LM (2005) Systemic and intraocular manifestations of West Nile virus infection. Surv Ophthalmol 50:3–13

Gilad R, Lampl Y, Sadeh M, Paul M, Dan M (2003) Optic neuritis complicating West Nile virus meningitis in a young adult. Infection 31:55–6 Gohari AZ, Willson RL, Gitter KA ((2011)) West Nile virus occlusive retinal

vasculitis. Retinal Cases & Brief Reports 2011 Bd. 5., S 209–12 Gyure KA (2009) West Nile virus infections. J Neuropathol Exp Neurol

68:1053–60

Halstead SB (2002) Dengue. Curr Opinion Infect Dis 15:471–6 Hershberger VS, Augsburger JJ, Hutchins RK et al (2003) Ophthalmology

110:1732–6

Jo T, Mizota A, Hatano N, Tanaka M (2006) Frosted branch angiitis like fundus following presumed influenza virus type A infection. Jpn J Ophthalmol 50:563–564

Jordan I, Briese N, Fischer N, Lau JY, Lipkin WI (2000) Ribavirin inhibits West Nile virus replication and cytopathic effect in neutral cells. J Infect Dis 182:1214–7

Kaiser PK, Lee MS, Martin DA (2003) Occlusive vasculitis in a patient with concomitant West Nile virus infection. Am J Ophthalmol 136:928–30

Kanungo S, Shukla D, Kim R (2008) Branch retinal artery occlusion secondary to dengue fever. Indian J Ophthalmol 56(1):73–4

Kapoor HK, Bhai S, John M, Xavier J (2006) Ocular manifestations of dengue fever in an East Indian epidemic. Can J Ophthalmol 41:741–6 Khairallah M, Yahia BS, Attia S, Jelliti B, Zaouali S, Ladjimi A (2006) Severe ischemic maculopathy in a patient with West Nile virus infection.

Ophthalmic Surg Lasers Imaging 37:240–2

Khairallah M, Yahia BS, Attia S (2010) Arthropod vector-borne uveitis in the developing world. Int Ophthalmol Clin 50:125–44

Khairallah M, Yahia BS, Toumi A et al (2009) Ocular manifestations associated with murine typhus. Br J Ophthalmol 93:938–42

Khairallah M, Yahia BS, Attia S et al (2006) Indocyanine green angiographic features in multifocal chorioretinitis associated with West Nile virus infection. Retina 26:358–9

Khairallah M, Yahia BS, Jelliti B et al (2009) Diagnostic value of ocular examination in Mediterranean spotted fever. Clin Microbiol Infect 15(2):273–4

1

2

3

4

5

6

7

8

10

11

12

13

14

15

16

17

18

19

20

21

22

392 Kapitel 9  •  Infektiös

Wichmann O, Lauschke A, Frank C et al (2005) Dengue antibody prevalence in German travelers. Emerg Infect Dis 11:762–5

World Health Organization (1997) Dengue hemorrhagic fever: diagnosis, treatment and control, 2. Aufl. WHO, Geneva, Switzerland

Literatur zu Abschn. 9.8

Accorinti M, Pirraglia MP, Corsi C, Caggiano C (2007) Vogt-Koyanagi- Harada disease after head trauma. Eur J Ophthalmol 17:847–852

Agrawal R, Shah M, Mireskandari K, Yong GK (2013) Controversies in ocular trauma classification and management: review. Int Ophthalmol 33:435–445

Blanch RJ, Good PA, Shah P, Bishop JRB, Logan A, Scott RAH (2013) Visual Outcomes after Blunt Ocular Trauma. Ophthalmology 120(8):1588– 91

Canavan YM, Archer DB (1982) Anterior segment consequences of blunt ocular injury. Br J Ophthalmol 66:549–555

Chu XK, Chan C-C (2013) Sympathetic ophthalmia: to the twenty-first century and beyond. J Ophthalmic Inflamm Infect 3:49

Cillino S, Casuccio A, Di Pace F, Pillitteri F, Cillino G (2008) A five-year retrospective study of the epidemiological characteristics and visual outcomes of patients hospitalized for ocular trauma in a Mediterranean area. BMC Ophthalmol 8:6

Dithmar S, Völcker HE, Grossniklaus HE (2000) Circumscribed choroidal granulomatous inflammation after perforating injury. A histopathological study of four eyes. Klin Monatsblätter Für Augenheilkd 217:236–239

Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805–2816

Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111:491–500 (discussion 500)

LeHoang P (2012) The gold standard of noninfectious uveitis: corticosteroids. Dev Ophthalmol 51:7–28

Marak GE, Aye MS, Alepa FP (1973) Cellular hypersensitivity in penetrating eye injuries. Invest Ophthalmol 12:380–382

Merlak M, Kovacević D, Balog T, Marotti T, Grzetić Lenac R, Romac I, Dekaris I (2008) Vascular endothelial growth factor in aqueous humor of patients with perforative eye injuries. Coll Antropol 32(2):33–37

Mete G, Turgut Y, Osman A, Gülşen U, Hakan A (2011) Anterior segment intraocular metallic foreign body causing chronic hypopyon uveitis. J Ophthalmic Inflamm Infect 1:85–87

Négrel AD, Thylefors B (1998) The global impact of eye injuries. Ophthalmic Epidemiol 5:143–169

Petrou P, Reddy MA (2008) Unusually resistant post-traumatic uveitis with high serum ACE-an occult ocular sarcoidosis? Ocul Immunol Inflamm 16:117–118

Pieramici DJ, Sternberg P, Aaberg TM, Bridges WZ, Capone A, Mieler WF, de Juan E, Kuhn F, Meredith TA, Cardillo JA et al (1997) A system for classifying mechanical injuries of the eye (globe). The Ocular Trauma Classification Group. Am J Ophthalmol 123:820–831

Rahi A, Morgan G, Levy I, Dinning W (1978) Immunological investigations in post-traumatic granulomatous and non-granulomatous uveitis. Br J Ophthalmol 62:722–728

Rosenbaum JT, Tammaro J, Robertson JE Jr (1991) Uveitis precipitated by nonpenetrating ocular trauma. Am J Ophthalmol 112:392–395 Scott R (2011) The injured eye. Philos Trans R Soc Lond B Biol Sci

366:251–260

Seymour R, Ramsey MS (1991) Unusually severe traumatic uveitis associated with occult ankylosing spondylitis. Can J Ophthalmol J Can Ophtalmol 26:156–158

Sihota R, Kumar S, Gupta V, Dada T, Kashyap S, Insan R, Srinivasan G (2008) Early predictors of traumatic glaucoma after closed globe

injury: trabecular pigmentation, widened angle recess, and higher baseline intraocular pressure. Arch Ophthalmol 126:921–926

Soheilian M, Rafati N, Mohebbi M-R, Yazdani S, Habibabadi HF, Feghhi M, Shahriary HA, Eslamipour J, Piri N, Peyman GA (2007) Prophylaxis of acute posttraumatic bacterial endophthalmitis: a multicenter, randomized clinical trial of intraocular antibiotic injection, report 2. Arch Ophthalmol 125:460–465

Spraul CW, Wagner P, Lang GE, Lang GK (2003) Ophthalmia nodosa caused by the hairs of the bird spider (family Theraphosidae) or hairy megalomorph (known in the US as tarantula)-case report and review of the literature. Klin Monatsblätter Für Augenheilkd 220:20–23

Tanito M, Kaidzu S, Katsube T, Nonoyama S, Takai Y, Ohira A (2009) Diagnostic Western blot for lens-specific proteins in aqueous fluid after traumatic lens-induced uveitis. Jpn J Ophthalmol 53:436–439 Thach AB, Marak GE Jr, McLean IW, Green WR (1991) Phacoanaphylactic endophthalmitis: a clinicopathologic review. Int Ophthalmol

15:271–279

Viestenz A, Küchle M (2004) Blunt ocular trauma. Part I: blunt anterior segment trauma. Ophthalmol Z Dtsch Ophthalmol Ges 101:1239– 1257 (quiz 1257–1258)

Viestenz A, Küchle M (2005) Blunt ocular trauma. Part II. Blunt posterior segment trauma. Ophthalmol Z Dtsch Ophthalmol Ges 102:89–99 (quiz 100–10)

Wilson MW, Grossniklaus HE, Heathcote JG (1996) Focal posttraumatic choroidal granulomatous inflammation. Am J Ophthalmol 121:397–404

Wirth MG, Helbig H (2005) Can eyelashes migrate? Klin Monatsblätter Für Augenheilkd 222:238–240

Wong TY, Klein BE, Klein R (2000) The prevalence and 5-year incidence of ocular trauma. The Beaver Dam Eye Study. Ophthalmology 107:2196–2202

Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, Zhu L, Ren Y, Klooster J, Kijlstra A (2005) Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30:943–948

Literatur zu Abschn. 9.9

Aaberg TM et al (1998) Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review on incidence and outcomes. Ophthalmology 105:1004–1010

Ahmed Y et al (2012) Endophthalmitis following open-globe injury. Eye 26:212–217

Adan A et al (2008) Pathological findings in the lens capsules and intraocular lens in chronic pseudophakic endophthalmitis: An electron microscopic study. Eye 22:113–119

Ahmed Y et al (2012) Endophthalmitis following open-globe injury. Eye 26:212–217

Aldave AJ et al (1999) Treatment strategies for postoperative propionibacterium acnes endophthalmitis. Ophthalmology 106:2395–2401 Allen HF, Mangiaracine AB (1964) Bacterial endophthalmitis after cataract extraction. A study of 22 infections in 20,000 operations. Arch

Ophthalmol 72:454–462

Al-Omran AM et al (2007) Microbiologic spectrum and visual outcome of posttraumatic endophthalmitis. Retina 27:236–242

Barza M et al (1997) Evaluation of microbiologic diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 115:1142–1150

Benz MS et al (2004) Endophthalmitis isolates and antibiotic sensivities: A 6-year review of culture-proven cases. Am J Ophthamol 137:38–42

Bhagat N et al (2011) Post-traumatic infectious endophthalmitis. Sur Ophthalmol 56:214–251

Literatur

Callegan MC et al (2002) Bacterial endophthalmitis: epidemiology, therapeutics and bacterium-host interactions. Clin Microbiol Rev 15:111–124

Chhabra S et al (2006) Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates. Am J Ophthalmol 142:852–854

Clark WL et al (1999) Treatment strategies and visual acuity outcomes in chronic postoperative propionibacterium acnes endophthalmitis. Ophthalmology 106:1665–1670

Cornut PL, Youssef B, Bron A, Thuret G, Gain P, Burillon C, Romanet JP, Vandenesch F, Maurin M, Creuzot-Garcher C, and Chiquet C (2013) A multicentre prospective study of post-traumatic endophthalmitis. Acta Ophthalmol 91(5):475–482

Eifrig CW et al (2002) Acute-onset postoperative endophthalmitis: Review of incidence and visual outcomes. Ophthalmic Surg Lasers 33:373–378

Endophthalmitis Vitrectomy Study Group (1995) Results of the Endophthalmitis Vitrectomy Study (A randomized trail of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113:1479–1496 Essex RW et al (2004) Post-traumatic endophthalmitis. Ophthalmol

111:2015–2022

Fintak DR et al (2008) Incidene of endophthalmitis related to intravitreal injection of bavacizumab and ranibizumab. Retina 28: 242:1395–9 Lyall et al (2012) Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye

26:1517–1526

Han DP et al (1996) Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 122:1–17

Hariprasad SM et al (2010) Voriconazole in the treatment of fungal eye infections: A review of the current literature. Br J Ophthalmol 92:871–878

Jackson TL et al (2003) Endogenous bacterial endophthalmitis: A 17year prospective series and review of 276 reported cases. Surv Ophthalmol 48:403–423

Kattan HM et al (1991) Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology 98:227–238

Kowalski RP et al (2012) The comparison of fluoroquinolons to nonfluoroquinolon antibacterial agents for the preention of endophthalmitis in a rabbit model. J Ocul Pharmacol Ther 28:604–608

Kuhn F, Gini G (2006) Ten years after … are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefes Arch Clin Exp Ophthalmol 243:1197–1199

Leng et al (2011) Delayed-onset bleb-associated endophthalmitis (1996–2008): Causative organism and visual acuity outcomes. Retina 31:344–352

Lohmann CP et al (2000) Improved detection of microorganisms by polymerase chain reaction in delayed endophthalmitis after cataract surgery. Ophthalmol 107:1047–1052

Lyell DA et al (2012) Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: Incidence, features, risk factors and outcomes. Eye 26:1517–1526

Maalouf F, Abdulaal M, and Hamam RN (2012) Chronic postoperative endophthalmitis: a review of clinical characteristics, microbiology, treatment strategies, and outcomes. Int.J Inflam 2012:313248

McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Retina 31:654–661

Miller JJ et al (2004) Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol 138:231–236

Mollan SP et al (2007) Postcataract endophthalmitis: incidence and microbial isolates in a United Kingdom region from 1996 through 2004. J Cataract Refract Surg 33:265–268

Moshefeghi et al (2011) Endophthalmitis after intravitreal anti-vascular endothelial growth vacot antagonists: A six-year experience at a university referral center. Retina 31:662–668

Neß T, Pelz K (2000) Endophthalmitis. Verbesserung des Keimnachweises. Ophthalmologe 97:33–37

Neß T et al (2007) Enodgenous endophthalmitis: Microorganism, disposition and prognosis. Ata Ophthalmol Acand 85:852–856

Park J et al (2012) A review of endophthalmitis following vitrectomy. www.medscape.org Paper ID 764374

Schiedler V et al (2004) Culture-proven endogenous endophthalmitis: Clinical features and visual outcomes. Am J Ophthalmol 137:725– 731

Scott IU et al (2008) Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: Incidence and outcomes. Retina 28:138–142

Scott IU et al (2011) Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefes arch vlin exp Ophthalmol 249:377–380

Shah CP et al (2011) Outocmes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Opthalmol 118:2028–34

Shirodkar AR et al (2012) Delayedversus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol 153:391–398

Simunovic MP et al (2012) Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: Clinical features causative organism and post-treatment outcomes. Br J Ophthalmol 96:862–866

Smiddy WE et al (2005) Subconjunctival antibiotics in the treatment of endophthalmitis without vitrectomy. Retina 25:751–758

Soriano F et al (2006) Streptococcus pneumoniae endophthalmitis: A a study of 36 cases with special reference to antibiotic resistance and treatment options. Clin Microbiol Infet 12:519–526

Speaker MG et al (1991) Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98:639–649

Taban M et al (2005) Acute endophthalmitis following cataract surgery: A systematic review of the literature. Arch Ophthalmol 123:613–620 Vallejo-Garcia JL, Asencio-Duran M, Pastora-Salvador N, Vinciguerra P, and Romano MR (2012) Role of inflammation in endophthalmitis.

Mediators Inflamm 2012:196094

West ES et al (2005) The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmol 112:1388–1394

Wu PC et al (2006) Nosocomial postoperative endophthalmitis: A 14year review. Graefes Arch Clin Exp Ophthalmol 244:920–929

Wykoff et al (2008) Exogenous fungal endophthalmitis microbiology and clinical outcomes. Ophthalmol 115:1501–1507

Wykoff et al (2010) Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital. Am J Ophthalmol 150:392– 398